Embolotherapy Market Scope And Analysis

  • Report Code : TIPRE00006432
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Embolotherapie-Marktumfang und SWOT-Analyse bis 2031

Buy Now

Embolotherapy Market Report Embolotherapy Market Size and Share Embolotherapy Market Scope and Analysis

Embolotherapy Market Report Scope

Report AttributeDetails
Market size in 2023US$ 3.88 Billion
Market Size by 2031US$ 7.37 Billion
Global CAGR (2023 - 2031)8.3%
Historical Data2021-2022
Forecast period2024-2031
Segments CoveredBy Product
  • Embolic Agent and Support Device
By Disease Indication
  • Cancer
  • Peripheral Vascular Disease
  • Neurological Disease
  • Urological & Nephrological Disorder
  • Gastrointestinal Disorder
  • Other
By Procedure
  • Transcatheter Arterial Embolization
By End User
  • Hospital & Clinic
  • Ambulatory Surgery Center
  • Other End User
Regions and Countries CoveredNorth America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Johnson & Johnson Consumer Inc
  • Medtronic
  • Acandis GmbH
  • Terumo Corporation
  • Balt USA LLC
  • Stryker Corporation
  • Guerbet LLC.
   Buy Now   
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Embolotherapy Market News and Recent Developments

The Embolotherapy market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the Embolotherapy market are listed below:

  • Terumo Medical Corporation announced the launch of the new AZUR HydroPack Peripheral Coil System in the United States. This coil is designed to find and fill space within the vessel, and it is the only packing coil that uses proprietary hydrogel technology to create a gel core for mechanical occlusion. (Source: Terumo Medical Corporation, Press Release, December 2023)
  • Guerbet announced it would double its line of microcatheters and launch a new line of guidewires, resulting in a broad range of interventional imaging and embolization solutions available. (Source: Guerbet, Press Release, March 2022)

Embolotherapy Market Report Coverage and Deliverables

Der Bericht „Marktgröße und Prognose für Embolotherapie (2021–2031)“ bietet eine detaillierte Analyse des Marktes und deckt die folgenden Bereiche ab:

  • Größe und Prognose des Embolotherapie-Marktes auf globaler, regionaler und Länderebene für alle wichtigen Marktsegmente, die unter den Geltungsbereich fallen
  • Markttrends für Embolotherapie sowie Marktdynamiken wie Treiber, Einschränkungen und wichtige Chancen
  • Detaillierte PEST/Porter's Five Forces- und SWOT-Analyse
  • Marktanalyse für Embolotherapie, die wichtige Markttrends, globale und regionale Rahmenbedingungen, Hauptakteure, Vorschriften und aktuelle Marktentwicklungen abdeckt3
  • Branchenlandschafts- und Wettbewerbsanalyse, die Marktkonzentration, Heatmap-Analyse, prominente Akteure und aktuelle Entwicklungen für den Embolotherapie-Markt umfasst
  • Detaillierte Firmenprofile